On Tuesday, Anvisa said it would maintain the suspension and did not give any indication of how long it might last, adding it required more information on the incident. A police report of the incident was seen by Reuters. Anvisa, in its statement on Wednesday, said the initial information it received about the case, which led to the suspension, had been incomplete and lacked the cause of the severe adverse event. It has strongly dismissed suggestions the decision could have been politically motivated. Anvisa, in its statement on Wednesday, said the initial information it received about the case, which led to the suspension, had been incomplete and lacked the cause of the severe adverse event. It has strongly dismissed suggestions the decision could have been politically motivated. The trials organizers criticized Anvisas decision, saying they had not been notified in advance and that there was no reason to stop the trial.
Anvisa said it would full out the vaccine.
( z0 say :ARG0 ( z1 person :name ( z2 name :op "Anvisa" ) ) :ARG1 ( z3 full :ARG0 ( z4 it ) :ARG1 ( z5 vaccine ) ) )
(z0 / say-01
    :ARG0 (z1 / person
              :name (z2 / name
                        :op1 "Anvisa"))
    :ARG1 (z3 / full-09
              :ARG0 (z4 / it)
              :ARG1 (z5 / vaccine)))
Anvisa said it would full out the vaccine .
z1 :name z2
z2 :op1 0
z0 :ARG0 z1
z3 :ARG0 z4
z0 :ARG1 z3
z3 :ARG1 z5